● 2024-10-2709:30-09:40题目: Safety assessment of biologics in the BRGSF-HIS: a highly predictive and translational mouse model演讲者:Dr. Gaelle Martin (法国genOway)第十四分会场:新型肿瘤免疫治疗(二)
● 2024-10-27
11:00-11:10
题目: Development of doubly humanized immune system and liver in mouse, a new tool for drug development and safety assessment
演讲者:Dr. Alexandre Fraichard(法国genOway CEO)
第十八分会场:血液免疫与心血管免疫、免疫学诊断与应用、新型免疫学技术与应用
壁报信息
285
● CD28 humanized mouse model for efficacy and safety assessment of CD28-targeting therapies
286
● Novel FcgR humanized mouse models enabling efficacy and PK/PD of therapeutic antibodie
287
● A novel translational mouse model for assessment of human STING-targeting therapies